The emerging role of osteoclasts in the treatment of bone metastases: rationale and recent clinical evidence. [PDF]
Front OncolLiu Y, Chen H, Chen T, Qiu G, Han Y.
europepmc +1 more source
Pre-treatment bone mineral density and the benefit of pharmacologic treatment on fracture risk and BMD change: analysis from the FNIH-ASBMR SABRE project. [PDF]
J Bone Miner ResSchini M +9 more
europepmc +1 more source
Benchmarking of Processes for the Biosynthesis of Natural Products [PDF]
, 2016 Seita, Catarina Sanches
core
The Management of Osteoporosis in Chronic Kidney Disease: A Review of Diagnostic and Therapeutic Approaches. [PDF]
CureusTariq F +9 more
europepmc +1 more source
Cathepsin K inhibitors increase distal femoral bone mineral density in rapidly growing rabbits [PDF]
AL Lerner +37 more
core +1 more source
Bidirectional crosstalk between the bone extracellular matrix and lysosomes in bone remodeling and osteoporosis. [PDF]
Front Endocrinol (Lausanne)Zhou C +8 more
europepmc +1 more source
Cathepsin K inhibitors promote osteoclast-osteoblast communication and engagement of osteogenesis. [PDF]
JBMR PlusPanwar P +4 more
europepmc +1 more source
Real-time quantification of soluble tartrate-resistant acid phosphatase as a measure of osteoclastogenesis. [PDF]
BiotechniquesRoosma JA +4 more
europepmc +1 more source
Three-Dimensionally Printed Scaffolds and Drug Delivery Systems in Treatment of Osteoporosis. [PDF]
Biomimetics (Basel)Codrea CI, Fruth V.
europepmc +1 more source